Tarsons Products Ltd Stock Price Today (NSE: TARSONS)
Fundamental Score
Tarsons Products Ltd Share Price — Live NSE/BSE Price, Fundamentals & Analysis
Tarsons Products Ltd share price today is ₹314.60, down 1.69% on NSE/BSE as of 31 July 2026. Tarsons Products Ltd (TARSONS) is a Small-cap company in the Medical Equipment & Supplies sector with a market capitalisation of ₹1.59K (Cr). The 52-week high for TARSONS share price is ₹382.10 and the 52-week low is ₹164.45. At a P/E ratio of 105.46x, TARSONS is currently trading above its industry average P/E of 36.70x. The company has a Return on Equity (ROE) of 2.38% and a debt-to-equity ratio of 0.62.
Tarsons Products Ltd Share Price Chart — NSE/BSE Historical Performance
Tarsons Products Ltd share price chart: 20.31% return over the past month. 52-week high ₹382.10, 52-week low ₹164.45.
Tarsons Products Ltd — Last 10 Trading Days
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| ₹319.35 | ₹326.00 | ₹312.15 | ₹314.60 | 1.22L (Cr) | |
| ₹313.45 | ₹334.90 | ₹310.00 | ₹320.00 | 1.22L (Cr) | |
| ₹323.95 | ₹325.00 | ₹306.45 | ₹310.95 | 80.12K (Cr) | |
| ₹313.00 | ₹326.35 | ₹313.00 | ₹320.90 | 2.09L (Cr) | |
| ₹294.95 | ₹328.85 | ₹292.10 | ₹312.05 | 68.70L (Cr) | |
| ₹285.00 | ₹293.20 | ₹278.00 | ₹281.35 | 86.60K (Cr) | |
| ₹300.00 | ₹302.10 | ₹285.55 | ₹287.45 | 1.23L (Cr) | |
| ₹300.95 | ₹307.75 | ₹294.55 | ₹299.50 | 83.86K (Cr) | |
| ₹314.85 | ₹320.55 | ₹307.00 | ₹308.75 | 1.87L (Cr) | |
| ₹304.50 | ₹326.45 | ₹300.55 | ₹315.90 | 5.56L (Cr) |
Tarsons Products Ltd — Last 12 Months Price History
| Month | Open | High | Low | Close | Change |
|---|---|---|---|---|---|
| ₹266.05 | ₹334.90 | ₹259.70 | ₹314.60 | +18.25% | |
| ₹207.99 | ₹284.40 | ₹199.41 | ₹267.99 | +28.85% | |
| ₹219.92 | ₹257.50 | ₹198.24 | ₹209.46 | -4.76% | |
| ₹168.60 | ₹222.90 | ₹168.60 | ₹219.92 | +30.44% | |
| ₹186.00 | ₹207.85 | ₹164.45 | ₹166.46 | -10.51% | |
| ₹196.00 | ₹234.67 | ₹184.30 | ₹190.80 | -2.65% | |
| ₹235.17 | ₹237.00 | ₹192.30 | ₹194.10 | -17.46% | |
| ₹225.99 | ₹243.80 | ₹213.40 | ₹233.30 | +3.23% | |
| ₹290.00 | ₹292.00 | ₹198.00 | ₹225.45 | -22.26% | |
| ₹305.00 | ₹309.95 | ₹286.00 | ₹289.05 | -5.23% | |
| ₹313.40 | ₹330.00 | ₹301.80 | ₹305.15 | -2.63% | |
| ₹362.00 | ₹382.10 | ₹308.60 | ₹311.80 | -13.87% |
AI Research Briefing
Powered by Gemini · 2026-04-09
Small-cap hope trade with brutal profitability headwinds; avoid until numbers prove the story.
WHAT'S HAPPENING NOW (last 2-4 weeks)
Tarsons Products closed its trading window on April 1, 2026, ahead of the FY26 audited results announcement. On March 30, 2026, the stock hit an all-time low of
CORE STORY (THE REAL GAME)
- Q3 FY26 showed QoQ revenue growth of 5.43%
- Operating profit increased QoQ by 9.91%
- Net profit jumped QoQ by 51.81%
- Stronger-than-expected earnings
- Significant order wins
- Successful integration of Nerbe acquisition
- Small-cap: liquidity risk
- High P/E ratio compared to industry average
- Negative operating profit growth over the past five years
FII decreased their stake by 3.32%
Medical devices sector in India is projected to grow, supported by infrastructure expansion and government initiatives
No free cash flow data available
Company aims to capitalize on the growing Indian plastic labware industry. Success depends on capacity expansion, product development, and navigating competitive pressures.
Primary Thesis Risk
Inability to translate revenue growth into sustained profitability.
For educational purposes only. Not investment advice. Consult a SEBI-registered advisor before investing.
Returns & Performance
Return on Equity (ROE)
Profit generated per ₹1 of shareholder equity
Return on Capital (ROCE)
Returns generated on total capital deployed
Oper. Profit Margin (5Y Avg)
Average operating profit margin over 5 years
Dividend Yield
Annual dividend as % of current share price
Tarsons Products Ltd Valuation Check
Price to Earnings (P/E)
Share price ÷ earnings per share. Lower = cheaper
Industry Avg P/E
Average P/E of all peers in this sector
Market Capitalisation
Total market value of all outstanding shares
Growth Engine
Profit Growth (Quarterly YoY)
Net profit growth vs same quarter last year
Revenue Growth (Quarterly YoY)
Revenue growth vs same quarter last year
Revenue Growth (5-Year CAGR)
Compounded annual revenue growth over 5 years
EPS Growth (5-Year CAGR)
Earnings per share growth over 5 years
Net Profit Growth (5-Year CAGR)
Compounded annual net profit growth over 5 years
Balance Sheet Health
Debt to Equity Ratio
Total debt ÷ equity. Below 0.5 = financially healthy
Interest Coverage Ratio
EBIT ÷ interest expense. Above 2.5 = can pay interest comfortably
Free Cash Flow (5-Year Total)
Cash left after capex over 5 years. Positive = self-funded growth
Labels (e.g., "Excellent", "Good") are peer-based vs industry/sector averages — data-only, not advice
Tarsons Products Ltd Fundamental Analysis & Valuation Benchmarking
Educational evaluation of TARSONS across key market metrics for learning purposes.
Positive Indicators
2 factors identified
Consistent Growth Track Record (13.04% CAGR)
Observation: Strong 5-year sales compound annual growth rate.
Analysis: Consistent sales CAGR >12% demonstrates sustainable growth model.
Zero Share Pledging Risk
Observation: No promoter shares pledged as collateral.
Analysis: Absence of share pledging eliminates potential forced-selling pressure.
Risk Factors
9 factors identified
Below-Average Return on Equity (2.38%)
Observation: Returns on equity are below industry benchmarks.
Analysis: ROE <10% may indicate inefficient capital utilization. Consider monitoring for operational improvements and management effectiveness.
Suboptimal ROCE (4.56%)
Observation: Returns on capital employed are below expectations.
Analysis: ROCE <10% suggests potential inefficiencies in capital allocation.
Premium Valuation Risk (P/E: 105.46x)
Observation: High valuation multiples may limit upside potential.
Analysis: Elevated P/E ratios require strong growth execution to justify current valuations.
Profit Decline Concern (-60.59%)
Observation: Significant year-over-year profit contraction observed.
Analysis: Declining profitability requires investigation into underlying causes.
Weak Earnings Growth (-76.03% CAGR)
Observation: Below-average 5-year EPS growth performance.
Analysis: Low EPS growth may not keep pace with inflation.
Stagnant Profit Growth (-26.20% CAGR)
Observation: Limited 5-year profit growth trajectory.
Analysis: Low profit growth may indicate scalability challenges or market maturity.
Weak Interest Coverage (2.02x)
Observation: Limited ability to service debt obligations from earnings.
Analysis: Low interest coverage raises concerns about financial stability.
Limited Institutional Interest (FII+DII: 1.06%)
Observation: Low institutional participation may affect liquidity.
Analysis: Limited institutional interest may indicate size constraints or visibility issues.
No Dividend Distribution
Observation: Company does not currently pay dividends to shareholders.
Analysis: Zero dividend yield may indicate growth reinvestment focus or cash flow constraints.
Tarsons Products Ltd vs Medical Equipment & Supplies Peers
Peer Comparison - Medical Equipment & Supplies
Compare Tarsons Products Ltd with 10 other companies in the same sector
| Company Info | Fundamental | Valuation | Profitability | Financial Health | Growth | Dividend | ||||
|---|---|---|---|---|---|---|---|---|---|---|
Company Company name | Score Bull Run comprehensive fundamental score based on 20+ metrics | Price Current trading price of the stock | Market Cap Total value of all shares in the market | P/E Price per share divided by earnings per share | ROE Net income divided by shareholder equity | ROCE Earnings before interest and tax divided by capital employed | Debt/Eq Total debt divided by total equity | Profit 5Y Average annual profit growth over 5 years | Sales 5Y Average annual sales growth over 5 years | Dividend Annual dividend per share divided by price per share |
Tarsons Products LtdTarsons Product...Selected✓ TARSONS • 543399 | 17.1/100 | ₹314.60₹315 | ₹1588.16₹1588.16 | 105.46Average 105.5 Average | 2.38%Poor 2.38% Poor | 4.56%Poor 4.56% Poor | 0.62Good 0.6 Good | -26.20%Poor -26.20% Poor | 13.04%Good 13.04% Good | 0.00% |
Poly Medicure LtdPoly Medicure L... POLYMED • 531768 | 55.6/100 | ₹1702.00₹1702 | ₹17395.50₹17395.50 | 53.16Average 53.2 Average | 11.15%Average 11.15% Average | 14.04%Average 14.04% Average | 0.11Excellent 0.1 Excellent | 19.35%Excellent 19.35% Excellent | 19.02%Excellent 19.02% Excellent | 0.20% |
Fischer Medical Ventures LtdFischer Medical... FISCHER • 524743 | 21.9/100 | ₹39.13₹39 | ₹2522.43₹2522.43 | 81.32Average 81.3 Average | 8.59%Poor 8.59% Poor | 11.43%Average 11.43% Average | 0.28Excellent 0.3 Excellent | — — | — — | 0.01% |
Laxmi Dental LtdLaxmi Dental Lt... LAXMIDENTL • 544339 | 69.6/100 | ₹212.69₹213 | ₹1227.22₹1227.22 | 36.70Average 36.7 Average | 14.80%Average 14.80% Average | 14.86%Average 14.86% Average | 0.05Excellent 0.1 Excellent | 103.10%Excellent 103.10% Excellent | 24.69%Excellent 24.69% Excellent | 0.00% |
OSEL DEVICES LIMITEDOSEL DEVICES LI... OSELDEVICE • | 67.9/100 | ₹413.05₹413 | ₹782.87₹782.87 | 26.76Average 26.8 Average | 19.56%Good 19.56% Good | 24.40%Excellent 24.40% Excellent | 0.49Excellent 0.5 Excellent | 84.72%Excellent 84.72% Excellent | 38.54%Excellent 38.54% Excellent | 0.00% |
HSIL LimitedHSIL Limited... HSIL • 543916 | 64.4/100 | ₹376.20₹376 | ₹547.99₹547.99 | 30.06Average 30.1 Average | 18.19%Good 18.19% Good | 19.64%Good 19.64% Good | 0.36Excellent 0.4 Excellent | 68.05%Excellent 68.05% Excellent | 31.02%Excellent 31.02% Excellent | 0.00% |
Prevest Denpro LtdPrevest Denpro ... PREVEST • 543363 | 61.5/100 | ₹401.65₹402 | ₹465.72₹465.72 | 21.74Average 21.7 Average | 18.51%Good 18.51% Good | 24.67%Excellent 24.67% Excellent | 0.00Excellent 0.0 Excellent | 24.33%Excellent 24.33% Excellent | 20.33%Excellent 20.33% Excellent | 0.26% |
38.2/100 | ₹147.10₹147 | ₹285.51₹285.51 | 56.65Average 56.6 Average | 7.54%Poor 7.54% Poor | 12.64%Average 12.64% Average | 0.10Excellent 0.1 Excellent | 42.43%Excellent 42.43% Excellent | 16.12%Excellent 16.12% Excellent | 0.00% | |
Nureca LtdNureca Ltd... NURECA • 543264 | 16.5/100 | ₹343.60₹344 | ₹260.07₹260.07 | 123.84Average 123.8 Average | 1.12%Poor 1.12% Poor | 3.30%Poor 3.30% Poor | 0.01Excellent 0.0 Excellent | -46.15%Poor -46.15% Poor | -7.19%Poor -7.19% Poor | 0.00% |
20.7/100 | ₹110.60₹111 | ₹216.85₹216.85 | 21.41Average 21.4 Average | 10.45%Average 10.45% Average | 13.18%Average 13.18% Average | 0.65Good 0.7 Good | — — | — — | 0.45% | |
32.1/100 | ₹193.50₹194 | ₹215.42₹215.42 | 23.96Average 24.0 Average | 11.99%Average 11.99% Average | 15.14%Good 15.14% Good | 0.03Excellent 0.0 Excellent | — — | — — | 0.00% | |
Top Medical Equipment & Supplies Stocks
View all →By Bull Run Score
By Return on Equity
By Market Cap
- Poly Medicure Ltd share price17395.50 Cr
- Fischer Medical Ventures Ltd share price2522.43 Cr
- Laxmi Dental Ltd share price1227.22 Cr
- OSEL DEVICES LIMITED share price782.87 Cr
- HSIL Limited share price547.99 Cr
Tarsons Products Ltd PE Ratio History
Historical price-to-earnings ratio for TARSONS — last 5 years
| Year | EPS (₹) | Price (₹) | P/E Ratio |
|---|---|---|---|
| FY 2025 | ₹5.60 | ₹233.30 | 41.7x |
| FY 2024 | ₹8.01 | ₹403.65 | 50.4x |
| FY 2023 | ₹15.17 | ₹527.30 | 34.8x |
| FY 2022 | ₹19.46 | ₹694.45 | 35.7x |
P/E = year-end price ÷ diluted EPS from annual filings. Source: NSE/BSE via Bull Run.
Tarsons Products Ltd Quarterly Performance
Latest quarterly metrics for TARSONS — revenue growth and profit growth vs same quarter last year
Revenue Growth (YoY)
7.31%
Latest quarter vs same quarter previous year
Net Profit Growth (YoY)
-60.59%
Latest quarter net profit vs same quarter previous year
5-Year Revenue CAGR
13.04%
Compounded annual revenue growth over 5 years
5-Year Profit CAGR
-26.20%
Compounded annual net profit growth over 5 years
Tarsons Products Ltd Technical Indicators
SMA 50, SMA 200, RSI and volume signals for TARSONS — calculated from daily price history
Momentum is balanced — neither overbought nor oversold.
Technical indicators are for educational purposes only. Not investment advice.
Tarsons Products Ltd Financial Statements
Annual income statement, balance sheet and cash flow for Tarsons Products Ltd (TARSONS) — sourced from NSE/BSE filings.
Loading Financial Statements...
Fetching financial data for Tarsons Products Ltd
About TARSONS (Tarsons Products Ltd)
Tarsons Products Ltd is a prominent Indian manufacturer specializing in the creation and distribution of high-quality laboratory plasticware. They offer a diverse catalog of produc...ts critical to scientific research and development, catering to a broad spectrum of applications within laboratories. The company's portfolio encompasses an array of essential items, carefully designed for precise and reliable use in various scientific procedures. From basic storage solutions to advanced consumables, Tarsons aims to provide researchers with the tools necessary to conduct experiments efficiently and accurately. Their commitment to quality materials and innovative designs underscores their dedication to supporting the scientific community. Tarsons' product line demonstrates a thorough understanding of the diverse needs of modern laboratories. Their offerings range from specialized containers for cell culture and cryopreservation to essential components for liquid handling and filtration. The meticulous design of their products considers factors like chemical compatibility, temperature resistance, and ease of use. Furthermore, the company recognizes the growing importance of genomics and PCR-based research, offering a comprehensive range of consumables optimized for these applications. By providing a wide selection of both disposable and reusable items, Tarsons strives to meet the varied requirements of different research settings, from academic institutions to industrial laboratories. Through a commitment to quality and a comprehensive product range, Tarsons Products Ltd plays a vital role in supporting the advancement of scientific discovery. Their products are integral to a multitude of research processes, offering scientists the tools they require to conduct experiments with precision and confidence. The company's unwavering focus on innovation and customer satisfaction solidifies its position as a trusted supplier of laboratory plasticware. Their reach extends beyond domestic markets, establishing Tarsons as a significant contributor to the global scientific community.
Company Details
Key Leadership
Corporate Events
Latest News
TARSONS Share Price: Frequently Asked Questions
What is the current share price of Tarsons Products Ltd?
Tarsons Products Ltd (TARSONS) trades at ₹314.60 on NSE and BSE. Market cap ₹1.59K (Cr). Educational data only.
What is the P/E ratio of Tarsons Products Ltd?
Tarsons Products Ltd has a P/E of 105.46x vs industry average 36.70x.
What is the Bull Run score for Tarsons Products Ltd?
Tarsons Products Ltd has a Bull Run score of 17.1/100 based on 25+ financial parameters.
Does Tarsons Products Ltd pay dividends?
Tarsons Products Ltd has a dividend yield of 0.00%. Past dividends don't guarantee future payments.
What is the ROE of Tarsons Products Ltd?
Tarsons Products Ltd has ROE of 2.38%. Higher ROE indicates better use of shareholder equity.
What is the debt-to-equity ratio of Tarsons Products Ltd?
Tarsons Products Ltd has debt-to-equity of 0.62.
Is Tarsons Products Ltd a good investment?
Bull Run gives Tarsons Products Ltd a score of 17.1/100. This is not investment advice — consult a SEBI-registered advisor.